Host Robin Young unpacks the Food and Drug Administration’s approval of a new drug that could treat pancreatic cancer with Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at the Dana Farber Cancer Institute.
This article was originally published on WBUR.org.
